Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Statins Use and the Risk of Prostate Cancer in Ischemic Heart Disease Patients in Taiwan.

Ho W, Choo DW, Wu YJ, Chan TF, Lin ZF.

Clin Pharmacol Ther. 2019 Feb 22. doi: 10.1002/cpt.1408. [Epub ahead of print]

PMID:
30801679
2.

Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database.

Lee J, Noh Y, Shin S, Lim HS, Park RW, Bae SK, Oh E, Kim GJ, Kim JH, Lee S.

Ther Clin Risk Manag. 2016 Oct 11;12:1533-1543. eCollection 2016.

3.

Statin Use Reduces Prostate Cancer All-Cause Mortality: A Nationwide Population-Based Cohort Study.

Sun LM, Lin MC, Lin CL, Chang SN, Liang JA, Lin IC, Kao CH.

Medicine (Baltimore). 2015 Sep;94(39):e1644. doi: 10.1097/MD.0000000000001644.

4.

Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.

Lin TK, Chou P, Lin CH, Hung YJ, Jong GP.

PLoS One. 2018 May 3;13(5):e0196713. doi: 10.1371/journal.pone.0196713. eCollection 2018.

5.

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.

PMID:
20206788
6.

Androgen Deprivation Therapy Use Increases the Risk of Heart Failure in Patients With Prostate Cancer: A Population-Based Cohort Study.

Kao HH, Kao LT, Li IH, Pan KT, Shih JH, Chou YC, Wu ST.

J Clin Pharmacol. 2019 Mar;59(3):335-343. doi: 10.1002/jcph.1332. Epub 2018 Nov 7.

PMID:
30402905
7.

Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.

Hamilton RJ, Banez LL, Aronson WJ, Terris MK, Platz EA, Kane CJ, Presti JC Jr, Amling CL, Freedland SJ.

Cancer. 2010 Jul 15;116(14):3389-98. doi: 10.1002/cncr.25308.

8.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.

PMID:
28753762
9.

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

Murtola TJ, Tammela TL, Määttänen L, Huhtala H, Platz EA, Ala-Opas M, Stenman UH, Auvinen A.

Int J Cancer. 2010 Oct 1;127(7):1650-9. doi: 10.1002/ijc.25165.

10.

Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan.

Chen JM, Chang CW, Chang TH, Hsu CC, Horng JT, Sheu WH.

PLoS One. 2014 Feb 10;9(2):e88434. doi: 10.1371/journal.pone.0088434. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100019.

11.

Statins, risk of diabetes, and implications on outcomes in the general population.

Wang KL, Liu CJ, Chao TF, Huang CM, Wu CH, Chen SJ, Chen TJ, Lin SJ, Chiang CE.

J Am Coll Cardiol. 2012 Oct 2;60(14):1231-8. doi: 10.1016/j.jacc.2012.05.019. Epub 2012 Aug 8.

12.

Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.

Harshman LC, Wang X, Nakabayashi M, Xie W, Valenca L, Werner L, Yu Y, Kantoff AM, Sweeney CJ, Mucci LA, Pomerantz M, Lee GS, Kantoff PW.

JAMA Oncol. 2015 Jul;1(4):495-504. doi: 10.1001/jamaoncol.2015.0829. Erratum in: JAMA Oncol. 2015 Jul;1(4):544.

13.

Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease.

Tsujimoto T, Kajio H.

Int J Cardiol. 2018 Mar 15;255:111-117. doi: 10.1016/j.ijcard.2017.12.109. Epub 2018 Jan 4.

PMID:
29307549
14.

Use of statins and the risk of death in patients with prostate cancer.

Yu O, Eberg M, Benayoun S, Aprikian A, Batist G, Suissa S, Azoulay L.

J Clin Oncol. 2014 Jan 1;32(1):5-11. doi: 10.1200/JCO.2013.49.4757. Epub 2013 Nov 4.

PMID:
24190110
15.

Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer.

Liu JM, Lin PH, Hsu RJ, Chang YH, Cheng KC, Pang ST, Lin SK.

Medicine (Baltimore). 2016 Aug;95(31):e4475. doi: 10.1097/MD.0000000000004475.

16.

Statin and metformin therapy in prostate cancer patients with hyperlipidemia who underwent radiotherapy: a population-based cohort study.

Li K, Si-Tu J, Qiu J, Lu L, Mao Y, Zeng H, Chen M, Lai C, Chang HJ, Wang D.

Cancer Manag Res. 2019 Feb 4;11:1189-1197. doi: 10.2147/CMAR.S166638. eCollection 2019.

17.

Examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus.

Dong YH, Lin JW, Wu LC, Chen CY, Chang CH, Chen KY, Lai MS.

J Formos Med Assoc. 2014 Dec;113(12):940-8. doi: 10.1016/j.jfma.2013.08.002. Epub 2013 Sep 16.

18.

Statins and prostate cancer diagnosis and grade in a veterans population.

Farwell WR, D'Avolio LW, Scranton RE, Lawler EV, Gaziano JM.

J Natl Cancer Inst. 2011 Jun 8;103(11):885-92. doi: 10.1093/jnci/djr108. Epub 2011 Apr 15.

19.

Statin drugs and risk of advanced prostate cancer.

Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E.

J Natl Cancer Inst. 2006 Dec 20;98(24):1819-25.

PMID:
17179483
20.

Statins increase the risk of prostate cancer: a population-based case-control study.

Chang CC, Ho SC, Chiu HF, Yang CY.

Prostate. 2011 Dec;71(16):1818-24. doi: 10.1002/pros.21401. Epub 2011 Apr 7.

PMID:
21480313

Supplemental Content

Support Center